Related Experiment Video
Updated: Aug 9, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Treatment of invasive squamous cell carcinoma with 5-percent imiquimod cream
M Konstantopoulou1, M G Lord, A W Macfarlane
1Department of Dermatology and Pathology, Ysbyty Gwynedd Hospital, Bangor, LL57 2PW, UK. Maria.Konstantopopoulou@nww-tr.wales.nhs.uk
Abstract:
Skin cancer is a major problem in the elderly. Squamous cell carcinoma (SCC), the second most common skin cancer, typically occurs in this age group. Despite a number of modalities readily available for treatment (depending on the tumor site, and depth of invasion) there remains the problem of individuals with multiple lesions who may be unsuitable for existing treatments for SCC, particularly surgery. Consequently, the search for novel treatments continues. To our knowledge, there are only 6 published reports of invasive SCC treated with 5-percent imiquimod cream.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Clinical Applications of Epidermal Stem Cells